Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: A cross-sectional and longitudinal study

Lupus

Volumn 18, Issue 9, 2009, Pages 785-791

  Dhir, V ^a   Singh, A P ^a   Aggarwal, A ^a   Naik, S ^a   Misra, Ramnath ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anti nucleosomal antibody; Lymphocyte apoptosis; Lymphocyte frequencies; Pathogenesis of lupus; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; INTERLEUKIN 10; LIPOCORTIN 5; NUCLEOSOME ANTIBODY; PREDNISOLONE;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOGENESIS; LONGITUDINAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCORING SYSTEM; STAINING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX; T LYMPHOCYTE;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; APOPTOSIS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-10; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NUCLEOSOMES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 67650637733     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309103152     Document Type: Article

References (30)

1. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
2. Miranda-Carus ME, Askanase AD, Clancy RM, et al. Anti-SSA/Ro and anti- SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000; 165: 5345-5351.
3. Graham KL, Utz PJ. Sources of autoantigens in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 513-517.
4. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
5. Strasser A, Whittingham S, Vaux DL, et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A 1991; 88: 8661-8665.
6. McNally J, Yoo DH, Drappa J, et al. Fas ligand expression and function in systemic lupus erythematosus. J Immunol 1997; 159: 4628-4636.
7. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685-3692.
8. Georgescu L, Vakkalanka RK, Elkon KB, Crow MK. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997; 100: 2622-2633.
9. Courtney PA, Crockard AD, Williamson K, McConnell J, Kennedy RJ, Bell AL. Lymphocyte apoptosis in systemic lupus erythematosus: Relationships with Fas expression, serum soluble Fas and disease activity. Lupus 1999; 8: 508-513.
10. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998; 7: 113-118.
11. Kalden JR. Defective phagocytosis of apoptotic cells: Possible explanation for the induction of autoantibodies in SLE. Lupus 1997; 6: 326-327.
12. WalporS MJ. Advances in immunology: Complement: second of two parts. N Engl J Med 2001; 344: 1140-1144.
13. Lorenz HM, Grünke M, Hieronymus T, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997; 40: 306-317.
14. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300.
15. Robak E, Sysa-Jedrzejowska A, Robak T, Smolewski P. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: Correlation with immunological status and disease-related symptoms. Clin Rheumatol 2006; 25: 225-233.
16. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 2006; 239: 121-128.
17. Gröndal G, Traustadottir KH, Kristjansdottir H, et al. Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus 2002; 11: 435-442.
18. Funauchi M, Sugiyama M. SukYoo, B, et al. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 2001; 10: 284-288.
19. Rivero SJ, Díaz-Jouanen E, Alarcón-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978; 21: 295-305.
20. Vilá LM, Alarcón GS, McGwin Jr G, Bastian HM, Fessler BJ, Reveille JD; Lumina Study Group. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006; 55: 799-806.
21. Muller S, Dieker J, Tincani A, Meroni PL. Pathogenic anti- nucleosome antibodies. Lupus 2008; 17: 431-435.
22. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
23. Wang H, Xu J, Ji X, et al. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 2005; 235: 117-121.
24. Silvestris F, Grinello D, Tucci M, Cafforio P, Dammacco F. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus. Lupus 2003; 12: 8-14.
25. Glinski W, Gershwin ME, Budman DR, Steinberg AD. Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Clin Exp Immunol 1976; 26: 228-238.
26. Messner RP, Lindström FD, Williams Jr RC. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest 1973; 52: 3046-3056.
27. Lies RB, Messner RP, Williams Jr RC. Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum 1973; 16: 369-375.
28. Shirai T, Yoshiki T, Mellors RC. Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice. Clin Exp Immunol 1972; 12: 455-464.
29. Amasaki Y, Kobayashi S, Takeda T, et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia. Clin Exp Immunol. 1995; 99: 245-250.
30. Cohen JJ, Duke RC. Glucocorticoid activation of a calciumdependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132: 38-42.